Peel Hunt reaffirmed their buy rating on shares of Eco Animal Health Group (LON:EAH) in a report issued on Friday morning.
Separately, Liberum Capital reiterated a buy rating and set a GBX 725 ($9.47) price target on shares of Eco Animal Health Group in a report on Monday, July 2nd.
Shares of EAH stock traded up GBX 5 ($0.07) during trading hours on Friday, reaching GBX 400 ($5.23). 30,957 shares of the company’s stock were exchanged, compared to its average volume of 39,512. Eco Animal Health Group has a fifty-two week low of GBX 485 ($6.34) and a fifty-two week high of GBX 680 ($8.89).
In other news, insider Anthony Paul Rawlinson sold 60,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 28th. The stock was sold at an average price of GBX 500 ($6.53), for a total transaction of £300,000 ($392,003.14).
Eco Animal Health Group Company Profile
ECO Animal Health Group plc develops and markets pharmaceutical products for animals worldwide. The company offers Aivlosin, a macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry. It also provides generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.
Further Reading: Should you buy a closed-end mutual fund?
Receive News & Ratings for Eco Animal Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eco Animal Health Group and related companies with MarketBeat.com's FREE daily email newsletter.